Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bailey

Showing results (531-540 of 560) with videos related to

Pageof 56
Sort By:
Regulatory Toxicology and Pharmacology : RTP|May 1, 2007
TIMES-SS--a promising tool for the assessment of skin sensitization hazard. A characterization with respect to the OECD validation principles for (Q)SARs and an external evaluation for predictivityGrace Patlewicz, Sabcho D Dimitrov, Lawrence K Low, et al.
Mucosal Immunology|April 10, 2026
The Nox2 NADPH oxidase regulates neutrophilic inflammation in the oral cavityShunying Jin, Richa Singhal, Jianzhu Luo, et al.
Brain, Behavior, and Immunity|February 21, 2026
Gut microbiota and metabolite disruption during breast cancer chemotherapy is associated with peripheral neuropathy sensory symptoms and painJeremy T Beales, Varshasnata Mohanty, Melina M Seng, et al.
The Journal of Clinical Investigation|January 18, 2014
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewalBing Zhou, Jeffrey S Damrauer, Sean T Bailey, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
VPA-985, a nonpeptide orally active and selective vasopressin V2 receptor antagonistP S Chan, J Coupet, H C Park, et al.
The Journal of Clinical Investigation|April 9, 2013
HIF1α and HIF2α independently activate SRC to promote melanoma metastasesSara C Hanna, Bhavani Krishnan, Sean T Bailey, et al.
Molecular Cancer Research : MCR|May 29, 2012
State of the science: an update on renal cell carcinomaEric Jonasch, P Andrew Futreal, Ian J Davis, et al.
Science Translational Medicine|November 16, 2018
Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinomaClaudio R Scafoglio, Brendon Villegas, Gihad Abdelhady, et al.
Aviation, Space, and Environmental Medicine|April 11, 1975
The effects of cosmic particle radiation on pocket mice aboard Apollo XVII: IX Results of examination of the nasal mucosaL M Kraft, F S Vogel, B Lloyd, et al.
The Journal of Clinical Investigation|August 16, 2021
Entinostat induces antitumor immune responses through immune editing of tumor neoantigensAndrew S Truong, Mi Zhou, Bhavani Krishnan, et al.
Pageof 56

Showing results (531-540 of 560) with videos related to

Sort By:
Pageof 56
Regulatory Toxicology and Pharmacology : RTP|May 1, 2007
TIMES-SS--a promising tool for the assessment of skin sensitization hazard. A characterization with respect to the OECD validation principles for (Q)SARs and an external evaluation for predictivityGrace Patlewicz, Sabcho D Dimitrov, Lawrence K Low, et al.
Mucosal Immunology|April 10, 2026
The Nox2 NADPH oxidase regulates neutrophilic inflammation in the oral cavityShunying Jin, Richa Singhal, Jianzhu Luo, et al.
Brain, Behavior, and Immunity|February 21, 2026
Gut microbiota and metabolite disruption during breast cancer chemotherapy is associated with peripheral neuropathy sensory symptoms and painJeremy T Beales, Varshasnata Mohanty, Melina M Seng, et al.
The Journal of Clinical Investigation|January 18, 2014
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewalBing Zhou, Jeffrey S Damrauer, Sean T Bailey, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
VPA-985, a nonpeptide orally active and selective vasopressin V2 receptor antagonistP S Chan, J Coupet, H C Park, et al.
The Journal of Clinical Investigation|April 9, 2013
HIF1α and HIF2α independently activate SRC to promote melanoma metastasesSara C Hanna, Bhavani Krishnan, Sean T Bailey, et al.
Molecular Cancer Research : MCR|May 29, 2012
State of the science: an update on renal cell carcinomaEric Jonasch, P Andrew Futreal, Ian J Davis, et al.
Science Translational Medicine|November 16, 2018
Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinomaClaudio R Scafoglio, Brendon Villegas, Gihad Abdelhady, et al.
Aviation, Space, and Environmental Medicine|April 11, 1975
The effects of cosmic particle radiation on pocket mice aboard Apollo XVII: IX Results of examination of the nasal mucosaL M Kraft, F S Vogel, B Lloyd, et al.
The Journal of Clinical Investigation|August 16, 2021
Entinostat induces antitumor immune responses through immune editing of tumor neoantigensAndrew S Truong, Mi Zhou, Bhavani Krishnan, et al.
Pageof 56